TY  - JOUR

T1  - APPENDIX D: Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy

JO  - Continuum

UR  - https://doi.org/10.1212/01.con.0000284530.12778.9b

PY  - 2007/01/01

AU  - 

ED  - 

DO  - DOI: 10.1212/01.con.0000284530.12778.9b

PB  - Ovid Technologies (Wolters Kluwer Health)

VL  - 13

IS  - 4

SP  - 212

EP  - 224

Y2  - 2025/11/09

ER  -